This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2016 Oct;39(10):1846.

doi: 10.2337/dc16-er10.

Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes

J Michael Gaziano, Anthony H Cincotta, Christopher M O'Connor, Michael Ezrokhi, Dean Rutty, Z J Ma, Richard E Scranton

PMID: 27660123
PMCID: PMC6908412
DOI: 10.2337/dc16-er10

Published Erratum

Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes

J Michael Gaziano et al. Diabetes Care. 2016 Oct.

. 2016 Oct;39(10):1846.

doi: 10.2337/dc16-er10.

Authors

J Michael Gaziano, Anthony H Cincotta, Christopher M O'Connor, Michael Ezrokhi, Dean Rutty, Z J Ma, Richard E Scranton

PMID: 27660123
PMCID: PMC6908412
DOI: 10.2337/dc16-er10

No abstract available

PubMed Disclaimer

Erratum for

Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes.
Gaziano JM, Cincotta AH, O'Connor CM, Ezrokhi M, Rutty D, Ma ZJ, Scranton RE. Gaziano JM, et al. Diabetes Care. 2010 Jul;33(7):1503-8. doi: 10.2337/dc09-2009. Epub 2010 Mar 23. Diabetes Care. 2010. PMID: 20332352 Free PMC article. Clinical Trial.

Similar articles

Quick-release bromocriptine for treatment of type 2 diabetes.
Mikhail N. Mikhail N. Curr Drug Deliv. 2011 Sep;8(5):511-6. doi: 10.2174/156720111796642255. Curr Drug Deliv. 2011. PMID: 21696353 Clinical Trial.
Focusing on cardiovascular disease in type 2 diabetes mellitus: an introduction to bromocriptine QR.
Bell DS. Bell DS. Postgrad Med. 2012 Sep;124(5):121-35. doi: 10.3810/pgm.2012.09.2598. Postgrad Med. 2012. PMID: 23095432 Review.
Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary.
Raskin P, Cincotta AH. Raskin P, et al. Expert Rev Endocrinol Metab. 2016 Mar;11(2):113-148. doi: 10.1586/17446651.2016.1131119. Expert Rev Endocrinol Metab. 2016. PMID: 30058874
Why does quick-release bromocriptine decrease cardiac events?
Bell DS. Bell DS. Diabetes Obes Metab. 2011 Oct;13(10):880-4. doi: 10.1111/j.1463-1326.2011.01424.x. Diabetes Obes Metab. 2011. PMID: 21569186 Review.
Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects.
[No authors listed] [No authors listed] J Am Heart Assoc. 2015 Oct 16;4(10):e001991. doi: 10.1161/JAHA.115.001991. J Am Heart Assoc. 2015. PMID: 26475299 Free PMC article. No abstract available.

See all similar articles

Cited by

Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review.
Birhan MT, Ayele TM, Abebe FW, Dgnew FN. Birhan MT, et al. Diabetol Metab Syndr. 2023 Jul 6;15(1):151. doi: 10.1186/s13098-023-01073-2. Diabetol Metab Syndr. 2023. PMID: 37415177 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

NODES